Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Medically reviewed by Renita White, MD Perimenopause is the transition period when the female body starts to shift from ...

The U.S. Food and Drug Administration (FDA) has issued its most serious warning -- a black-box warning -- for Veozah, a medication used to relieve hot flashes in menopausal women, due to rare but ...

For many women who experience hot flashes, the new drug Veozah has been a life-changer. And a heightened warning last month, doesn’t seem to be dampening that enthusiasm.

Veozah was approved in 2023. At the time, it was the first non-hormonal prescription option for treating hot flashes. The medication works by blocking neurokinin B, a receptor involved in the ...

Charity Scott, a 51-year-old trauma therapist in Los Angeles, entered menopause in May this year but has been dealing with hot flashes ... had success with over-the-counter supplements, Scott ...

and hot flashes, according to Dr. Kavita Desai ... From lubricants to shampoos to supplements—there are now countless over-the-counter products designed to alleviate the symptoms of menopause.